Document:

Exhibit 4.1

    Exhibit
      4.1

    
 

    WRITTEN
      CONSENT OF THE

    CONSULTANT
      AND VENDOR COMPENSATION COMMITTEE 

    OF
      THE BOARD OF DIRECTORS TO CORPORATE ACTION 

    BY
      COBALIS CORP.,

    a
      Nevada Corporation

    

    The
      undersigned are the only members of, and, therefore, constitute, the entire
      Consultant and Vendor Compensation Committee appointed by the Board of Directors
      of Cobalis Corp., a Nevada corporation (“Corporation”); the members of the
      Consultant and Vendor Compensation Committee and hereby consent, by this
      writing, to take the following action, to adopt the following resolutions,
      and
      to transact the following business of this Corporation:

    

    RESOLVED,
      that pursuant to the undersigned have determined that it is in the best
      interests of this Corporation and its shareholders to approve the issuance
      of
      certain shares of its $.001 par value (“Shares”) to be issued
      to the
      consultants listed on Exhibit A indicated as payment for the services rendered
      as specified on Exhibit A, and that all these shares are to be registered
      pursuant to a Registration Statement on Form S-8; 

    

    RESOLVED,
      this Corporation believes that, in accordance with that resolution by the
      Consultant and Vendor Compensation Committee regarding the issuance of the
      Shares, it is in the best interests of the Corporation and its shareholders
      to
      cause to be prepared a Registration Statement on Form S-8, pursuant to which
      the
      Corporation undertakes to register those shares of the Corporation’s $.001 par
      value common stock,
      and
      that this
      Corporation shall therewith undertake the necessary actions to prepare and
      file
      with the Securities and Exchange Commission, a Registration Statement on Form
      S-8 and any required amendments for the registration of those
      Shares;

    

    RESOLVED,
      FURTHER, that the Corporation shall issue and deliver to those individuals
      specified, in accordance with the underlying agreements pertaining thereto,
      the
      certificates representing shares of the Corporation’s $.001 par value common
      stock as noted; and, that these shareholders shall have all rights and
      privileges of shareholders of this Corporation, from this date forward, and
      that
      the shares so issued shall be fully paid and non-assessable, so that the
      consideration for such shares shall be the services received or to be rendered;
      and

    

    RESOLVED,
      FURTHER, the officers of this Corporation be, and hereby are, authorized,
      empowered and directed to take any and all action and shall enter into, execute
      and deliver any and all documents which those officers determine are necessary
      or appropriate to effectuate and carry out the intents and purposes of the
      resolutions specified in this Consent.

    

    THIS
      CONSENT is executed pursuant to the provisions of Section 78.315 of the Nevada
      Revised Statutes in accordance with the Bylaws of the Corporation and is to
      be
      filed with the minutes of proceedings of the Board of Directors of this
      Corporation.

     

     

    
      	 	 	 	 
	Dated:
              April 17,
              2006	 	 	/s/ Chaslav
              Radovich
	
            	 	 	
              
Chaslav
              Radovich, Director

    

     

    
       

      
        
          	 	 	 	 
	Dated:
                  April 17,
                  2006	 	 	/s/ Radul
                  Radovich
	
                	 	 	
                  
Radul
                  Radovich, Director

          

          
            	 	 	 	 
	Dated:
                    April 17,
                    2006	 	 	/s/ Ernest
                    Armstrong
	
                  	 	 	
                    
Ernest
                    Armstrong,
                    Director

        

      

    

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

     

    Exhibit
      A

     

    
      	
              Recipient

            	
              Shares

            	
              Services

            
	
              Matthew
                Clayton

            	
              7,500

            	
              Product
                manufacturing

            
	
              Robert
                Mackie

            	
              7,500

            	
              Product
                manufacturing

            
	
              Ryan
                Neely

            	
              7,353

            	
              EDGARization
                services

            
	
              William
                Hitchcock

            	
              8,730

            	
              Accounting
                services

            
	
              Mark
                Rumph

            	
              4,000

            	
              Information
                technology consulting and support

            
	
              Andrew
                Callari

            	
              10,000

            	
              Legal
                services

            
	
              Vesna
                Petrovic

            	
              3,000

            	
              Product
                design

            
	
              Lyndon
                Mansfield

            	
              20,000

            	
              Medical
                Advisor - clinical trials

            
	
              David
                Filler

            	
              30,000

            	
              Legal
                Services

            
	
              Catherine
                Rodriguez

            	
              10,000

            	
              Legal
                Services

            
	
              Kate
                Corrigan

            	
              3,333

            	
              Legal
                services

            
	
              Total
                Shares:

            	
              111,416

            	 

    

    

    2Exhibit 4.2

    Exhibit
      4.2

     

    

      
        	
                MDC
                  Enterprises Ltd.

              	 	
                INVOICE

              
	 	 	 
	 	 	 
	
                Suite
                  300, 1275 West 6th Ave.

              	
                DATE:

              	
                January
                  16,  2006

              
	
                Vancouver,
                  BC, Canada, V6H 1A6

              	
                INVOICE
                  #

              	
                100
                  revised

              
	
                Phone
                  604.505.4833 

                Fax
                  604.244.8399

              	
                FOR:

              	
                Compassion,
                  Migrain, 

                and
                  Bioavail

              
	 	 	 
	
                Bill
                  To:

              	 	 
	
                Cobalis
                  Corp.

              	
                 

              	
                 

              
	
                2445
                  McCabe Way, Suite 150

              	
                 

              	
                 

              
	
                Irvine,
                  CA, USA, 92614

              	
                 

              	
                 

              
	
                949.757.0001

              	
                 

              	
                 

              
	
                Fax
                  949.757.0979

              	 	 
	 	 	 
	
                DESCRIPTION

              	
                AMOUNT

              
	
                Compassion
                  Blister Packs:

              	 	 
	
                1,850
                  units of 60 lozenge blister packed "Compassion Packs" @ 8.35 USD
                  each

              	 	
                $15,447.50
                  

              
	
                Cobalis
                  to provide artwork for out box

              	 	 
	 	 	 
	
                Bioavailability
                  Study:

              	 	 
	
                Bioavailability
                  study 1 unit of 300 3.3mg lozenges bottled.

              	 	
                $75.00
                  

              
	
                Bioavailability
                  study 1 unit of 300 6.6mg lozenges bottled.

              	 	
                $75.00
                  

              
	
                Cobalis
                  to provide label artwork/file

              	 	 
	 	 	 
	
                Migran
                  Study:

              	 	 
	
                100
                  units of 120 Placebo lozenges @ $11.40 per unit

              	 	
                $1,140.00
                  

              
	
                100
                  units of 120 3.3mg lozenges @ $11.40 per unit

              	 	
                $1,140.00
                  

              
	
                100
                  units of 120 6.6mg lozenges @ $11.40 per unit

              	 	
                $1,140.00
                  

              
	 	 	 
	
                Allergy
                  Study:

              	 	 
	
                To
                  be billed separately after study design is complete.

              	 	 
	 	
                TOTAL
                  

              	
                $
                  19,017.50 

              
	 	 	 
	 	 	 
	
                Make
                  all checks payable to MDC
                  Enterprises Ltd. Please Mail your check to the above mentioned
                  address.

              
	
                If
                  you have any questions concerning this invoice, contact Huff Taylor,
                  604-505-4833, huff@advancedbotanicals.com 

              
	
                 THANK
                  YOU FOR YOUR
                  BUSINESS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}]]